PubMed Health⌕ Search

Biomedical subjects

Robert McGuire

Publications and source records attributed to Robert McGuire.

3 recordsLinked to original sources

Synthesis, electrochemistry and luminescence of [Pt{4'-(R)trpy}(CN)](+) (R = Ph, o-CH(3)C(6)H(4), o-ClC(6)H(4) or o-CF(3)C(6)H(4); trpy = 2,2':6',2''-terpyridine): crystal structure of [Pt{4'-(Ph)trpy}(CN)]BF(4) x CH(3)CN.

The synthesis and characterization of [Pt{4'-(R)trpy}(CN)]X (R = Ph, X = BF(4) or SbF(6); R = o-CH(3)C(6)H(4), X = SbF(6); R = o-ClC(6)H(4), X = SbF(6); or R = o-CF(3)C(6)H(4), X = SbF(6)) are described where trpy = 2,2':6',2''-terpyridine. Single crystals of [Pt{4'-(Ph)trpy}(CN)]BF(4).CH(3)CN were grown by vapour diffusion of diethyl ether into an acetonitrile solution of [Pt{4'-(Ph)trpy}(CN)]BF(4). An X-ray crystal structure determination of the solvated complex confirms the near linear coordination of the cyanide ligand to the platinum centre. The cation is almost planar as evidenced by a twist of only 1.9 degrees of the phenyl group out of the plane of the terpyridyl moiety. Cyclic voltammograms were recorded in DMF/0.1 M TBAH for the [Pt{4'-(R)trpy}(CN)](+) cations. Two quasi-reversible one-electron reduction (cathodic) waves are observed with E(1/2) values that show the trend expected for an increasingly lower energy of the trpy-based LUMO of the complex i.e., [Pt{4'-(Ph)trpy}(CN)](+) approximately [Pt{4'-(o-CH(3)C(6)H(4))trpy}(CN)](+) < [Pt{4'-(o-ClC(6)H(4))trpy}(CN)](+) < [Pt{4'-(o-CF(3)C(6)H(4))trpy}(CN)](+). All the [Pt(4'-(R)trpy}(CN)](+) cations are photoluminescent in dichloromethane. Emission by [Pt{4'-(Ph)trpy}(CN)](+) is from an excited state with largely (3)MLCT orbital parentage, but with some intraligand (3)pi-pi* character mixed-in (tau = 0.1 micros). In contrast, the other three cations display emission that appears exclusively intraligand (3)pi-pi* in origin (tau approximately 0.8 micros). Emission spectra have been recorded in a low concentration frozen DME {1 : 5 : 5 (v/v) DMF-MeOH-EtOH} glass. For the R = o-CH(3)C(6)H(4), o-ClC(6)H(4) and o-CF(3)C(6)H(4) cations the envelope of vibronic structure and energies of the vibrational components are essentially the same as that recorded in dichloromethane. However, for the [Pt{4'-(Ph)trpy}(CN)](+) cation, there is a blue-shift in the energies of the vibrational components as compared to that recorded in dichloromethane, as well as a change in the envelope of vibronic structure to a more "domed" pattern; this has been interpreted in terms of a higher percentage of intraligand (3)pi-pi* character in the emitting state for the glass. Increasing the concentration of the glass invariably leads to aggregation of the cations and the consequent development of new low energy bands, such that at 0.200 mM broad peaks centred at ca. 650 and 700 nm dominate the spectrum; these bands are assigned to excimeric (3)pi-pi* and (3)MMLCT emission, respectively.

Journal Article↗

One-dimensional supramolecular assemblies based on a Re2(III,III) synthon and their solid-state phosphorescence.

Reactions between Re2(DMBA)4(NO3)2 (1; DMBA is dimethylbenzamidinate) and a bidentate dianion, either tungstate (WO4(2-)) or terephthalte (1,4-(O2C)2C6H4(2-)), resulted in the one-dimensional coordination polymers [Re2(DMBA)4(mu-O,O'-WO4)](infinity) (2) and [Re2(DMBA)4(mu-O,O'-1,4-(O2C)2C6H4)](infinity) (3), respectively. Both polymers display phosphorescence from a 3(delta --> delta*) state, which is significantly blue shifted from the phosphorescence previously observed for Re2(DMBA)4Cl2 type compounds.

Journal Article↗

Lumbar spinal stenosis: indications for arthrodesis and spinal instrumentation.

Surgical indications for simple decompression in patients with lumbar spinal stenosis are well established. Following these guidelines, surgeons can expect good and excellent outcomes in 75% to 90% of patients. Despite the publication of many studies pertaining to the addition of arthrodesis and instrumentation, the indications for adding these procedures to a decompression are much less clear. Preoperative and intraoperative factors must be carefully considered when contemplating the addition of arthrodesis in the setting of spinal stenosis. In patients with preoperative degenerative spondylolisthesis, scoliosis, or kyphosis, and those in whom stenosis develops at a previously decompressed segment, serious consideration should be givenfor inclusion of an arthrodesis. Fusion should also be considered for those patients with stenosis adjacent to a previously fused lumbar segment. Excision of a significant portion of the facet joints or radical excision of the intervertebral disk during the course of the decompression predispose the patient to postoperative instability. The addition of an arthrodesis will likely benefit these patients. Relative indications for the use of spinal instrumentation in the setting of spinal stenosis include correction of deformity, recurrent spinal stenosis with instability, degenerative spondylolisthesis, adjacent segment stenosis with instability, and multiple level fusions.

Arthrodesis↗